Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2006

Conditions
Cancer of the Ovary Treated as 2nd Line TherapyMuellerian Mixed TumoursTumours of the UterusCervical CancersNon-Epithelial Ovarian Tumours
Interventions
DRUG

Pegylated Liposomal Doxorubicin and Carboplatin

Trial Locations (19)

10367

Medical Practice Dr. Klare, Berlin

17487

Ernst-Moritz-Arndt University, Dept. of Gynecology & Obstetrics, Greifswald

24105

Univerisity Clinic Schleswig-Holstein, Campus Kiel, Dept. for gynecology & obstetrics, Kiel

30625

MH Hannover, Dept. of Gynecology & Obstetrics, Hanover

35033

Phillips University, Clinic fo gynecology, gyn endocrinology and oncology, Marburg

39108

Otto-von-Guericke Univerisity, Dept. of Gynecology & Obstetrics, Magdeburg

40217

Evangelisches Krankenhaus, Dept. of Gynecology & Obstetrics, Düsseldorf

45122

University hospital, Dept. of gynecology & obstetrics, Essen

55101

University hospital, Dept. of Gynecology & Obstetrics, Mainz

60596

University hospital , Dept. gynecologic & obestretics, Frankfurt

72076

University hospital, Dept. gynecology & obstetrics, Tübingen

76137

St. Vincentius Hospital, Dept. of Gynecology & Obstetrics, Karlsruhe

78050

Schwarzwald-Baar Klinikum Villingen, Dept. Gynecology, Villingen-Schwenningen

79106

University of Freiburg; Dept of Gynecology & Obstetrics, Freiburg im Breisgau

81377

University hospital Muenchen-Grosshadern, Dept. of gynecology & obstetrics, München

81675

University Hospital TU Muenchen; Dept. of Gynecology & Obstetrics, München

91054

Univerisity Hospital; Dept. of Gynecology & Obstetrics, Erlangen

08529

Humaine Vogtlandklinikum; Dept. of gynecology & obstetrics, Plauen

D-65199

HSK, Dr. Horst Schmidt Klinik, Dept. of Gynecology & Gyn. Oncology, Wiesbaden

All Listed Sponsors
collaborator

MedServ. GmbH, Wiesbaden

UNKNOWN

collaborator

Essex Pharma GmbH

INDUSTRY

lead

AGO Study Group

OTHER

NCT00189410 - Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours | Biotech Hunter | Biotech Hunter